Skip to main content
. 2021 Nov 22;5(22):4762–4770. doi: 10.1182/bloodadvances.2021004619

Table 4.

Response in total population, in transformed FL and by COO subtype

GCB ABC Unclassified Total
Patients, n 15 5 19 39
 ORR, n (%) 7 (46.7) 1 (20.0) 7 (36.8) 15 (38.5)
 CR, n (%) 3 (20.0) 0 5 (26.3) 8 (20.5)
N-transformed FL
 Patients, n 3 0 5 8
 ORR-transformed FL, n (%) 2 (67.7) 0 3 (60.0) 5 (62.5)